Pharma & Healthcare
Global Canine Vaccine Market Research Report 2026
- Feb 03, 26
- ID: 693133
- Pages: 120
- Figures: 119
- Views: 4
This report delivers a comprehensive overview of the global Canine Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Canine Vaccine. The Canine Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Canine Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Canine Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Pfizer
Boehringer Ingelheim
Virbac
Durvet
Elanco
RuiPu Bio-Technology
CAHIC
Wuhan Keqian Biology
Jilin Five-Star Animal Health
NeoTech
JINHE
SINOVAC
Biogenesis Bago
Segment by Type
Core Vaccines
Non-Core Vaccines
by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Canine Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Canine Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Canine Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Canine Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Pfizer
Boehringer Ingelheim
Virbac
Durvet
Elanco
RuiPu Bio-Technology
CAHIC
Wuhan Keqian Biology
Jilin Five-Star Animal Health
NeoTech
JINHE
SINOVAC
Biogenesis Bago
Segment by Type
Core Vaccines
Non-Core Vaccines
by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Canine Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Canine Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Canine Vaccine Market Overview
1.1 Product Definition
1.2 Canine Vaccine by Type
1.2.1 Global Canine Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Core Vaccines
1.2.3 Non-Core Vaccines
1.3 Canine Vaccine by Application
1.3.1 Global Canine Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global Canine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Canine Vaccine Revenue 2021–2032
1.4.2 Global Canine Vaccine Sales 2021–2032
1.4.3 Global Canine Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Canine Vaccine Market Competition by Manufacturers
2.1 Global Canine Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Canine Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Canine Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Canine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Canine Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Canine Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Canine Vaccine, Date of Entry into the Industry
2.8 Global Canine Vaccine Market Competitive Situation and Trends
2.8.1 Global Canine Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Canine Vaccine Players Market Share by Revenue
2.8.3 Global Canine Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Canine Vaccine Market Scenario by Region
3.1 Global Canine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Canine Vaccine Sales by Region: 2021–2032
3.2.1 Global Canine Vaccine Sales by Region: 2021–2026
3.2.2 Global Canine Vaccine Sales by Region: 2027–2032
3.3 Global Canine Vaccine Revenue by Region: 2021–2032
3.3.1 Global Canine Vaccine Revenue by Region: 2021–2026
3.3.2 Global Canine Vaccine Revenue by Region: 2027–2032
3.4 North America Canine Vaccine Market Facts & Figures by Country
3.4.1 North America Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Canine Vaccine Sales by Country (2021–2032)
3.4.3 North America Canine Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Canine Vaccine Market Facts & Figures by Country
3.5.1 Europe Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Canine Vaccine Sales by Country (2021–2032)
3.5.3 Europe Canine Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Canine Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Canine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Canine Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Canine Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Canine Vaccine Market Facts & Figures by Country
3.7.1 Latin America Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Canine Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Canine Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Canine Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Canine Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Canine Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Canine Vaccine Sales by Type (2021–2032)
4.1.1 Global Canine Vaccine Sales by Type (2021–2026)
4.1.2 Global Canine Vaccine Sales by Type (2027–2032)
4.1.3 Global Canine Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Canine Vaccine Revenue by Type (2021–2032)
4.2.1 Global Canine Vaccine Revenue by Type (2021–2026)
4.2.2 Global Canine Vaccine Revenue by Type (2027–2032)
4.2.3 Global Canine Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Canine Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Canine Vaccine Sales by Application (2021–2032)
5.1.1 Global Canine Vaccine Sales by Application (2021–2026)
5.1.2 Global Canine Vaccine Sales by Application (2027–2032)
5.1.3 Global Canine Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Canine Vaccine Revenue by Application (2021–2032)
5.2.1 Global Canine Vaccine Revenue by Application (2021–2026)
5.2.2 Global Canine Vaccine Revenue by Application (2027–2032)
5.2.3 Global Canine Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Canine Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis Canine Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health Canine Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Canine Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac Canine Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Durvet
6.6.1 Durvet Company Information
6.6.2 Durvet Description and Business Overview
6.6.3 Durvet Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Durvet Canine Vaccine Product Portfolio
6.6.5 Durvet Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elanco Canine Vaccine Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 RuiPu Bio-Technology
6.8.1 RuiPu Bio-Technology Company Information
6.8.2 RuiPu Bio-Technology Description and Business Overview
6.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
6.8.5 RuiPu Bio-Technology Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CAHIC Canine Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Jilin Five-Star Animal Health
6.11.1 Jilin Five-Star Animal Health Company Information
6.11.2 Jilin Five-Star Animal Health Description and Business Overview
6.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates
6.12 NeoTech
6.12.1 NeoTech Company Information
6.12.2 NeoTech Description and Business Overview
6.12.3 NeoTech Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 NeoTech Canine Vaccine Product Portfolio
6.12.5 NeoTech Recent Developments/Updates
6.13 JINHE
6.13.1 JINHE Company Information
6.13.2 JINHE Description and Business Overview
6.13.3 JINHE Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JINHE Canine Vaccine Product Portfolio
6.13.5 JINHE Recent Developments/Updates
6.14 SINOVAC
6.14.1 SINOVAC Company Information
6.14.2 SINOVAC Description and Business Overview
6.14.3 SINOVAC Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 SINOVAC Canine Vaccine Product Portfolio
6.14.5 SINOVAC Recent Developments/Updates
6.15 Biogenesis Bago
6.15.1 Biogenesis Bago Company Information
6.15.2 Biogenesis Bago Description and Business Overview
6.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Biogenesis Bago Canine Vaccine Product Portfolio
6.15.5 Biogenesis Bago Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Canine Vaccine Industry Chain Analysis
7.2 Canine Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Canine Vaccine Production Mode & Process Analysis
7.4 Canine Vaccine Sales and Marketing
7.4.1 Canine Vaccine Sales Channels
7.4.2 Canine Vaccine Distributors
7.5 Canine Vaccine Customer Analysis
8 Canine Vaccine Market Dynamics
8.1 Canine Vaccine Industry Trends
8.2 Canine Vaccine Market Drivers
8.3 Canine Vaccine Market Challenges
8.4 Canine Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Canine Vaccine by Type
1.2.1 Global Canine Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Core Vaccines
1.2.3 Non-Core Vaccines
1.3 Canine Vaccine by Application
1.3.1 Global Canine Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global Canine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Canine Vaccine Revenue 2021–2032
1.4.2 Global Canine Vaccine Sales 2021–2032
1.4.3 Global Canine Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Canine Vaccine Market Competition by Manufacturers
2.1 Global Canine Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Canine Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Canine Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Canine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Canine Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Canine Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Canine Vaccine, Date of Entry into the Industry
2.8 Global Canine Vaccine Market Competitive Situation and Trends
2.8.1 Global Canine Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Canine Vaccine Players Market Share by Revenue
2.8.3 Global Canine Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Canine Vaccine Market Scenario by Region
3.1 Global Canine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Canine Vaccine Sales by Region: 2021–2032
3.2.1 Global Canine Vaccine Sales by Region: 2021–2026
3.2.2 Global Canine Vaccine Sales by Region: 2027–2032
3.3 Global Canine Vaccine Revenue by Region: 2021–2032
3.3.1 Global Canine Vaccine Revenue by Region: 2021–2026
3.3.2 Global Canine Vaccine Revenue by Region: 2027–2032
3.4 North America Canine Vaccine Market Facts & Figures by Country
3.4.1 North America Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Canine Vaccine Sales by Country (2021–2032)
3.4.3 North America Canine Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Canine Vaccine Market Facts & Figures by Country
3.5.1 Europe Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Canine Vaccine Sales by Country (2021–2032)
3.5.3 Europe Canine Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Canine Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Canine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Canine Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Canine Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Canine Vaccine Market Facts & Figures by Country
3.7.1 Latin America Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Canine Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Canine Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Canine Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Canine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Canine Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Canine Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Canine Vaccine Sales by Type (2021–2032)
4.1.1 Global Canine Vaccine Sales by Type (2021–2026)
4.1.2 Global Canine Vaccine Sales by Type (2027–2032)
4.1.3 Global Canine Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Canine Vaccine Revenue by Type (2021–2032)
4.2.1 Global Canine Vaccine Revenue by Type (2021–2026)
4.2.2 Global Canine Vaccine Revenue by Type (2027–2032)
4.2.3 Global Canine Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Canine Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Canine Vaccine Sales by Application (2021–2032)
5.1.1 Global Canine Vaccine Sales by Application (2021–2026)
5.1.2 Global Canine Vaccine Sales by Application (2027–2032)
5.1.3 Global Canine Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Canine Vaccine Revenue by Application (2021–2032)
5.2.1 Global Canine Vaccine Revenue by Application (2021–2026)
5.2.2 Global Canine Vaccine Revenue by Application (2027–2032)
5.2.3 Global Canine Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Canine Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis Canine Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health Canine Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Canine Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac Canine Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Durvet
6.6.1 Durvet Company Information
6.6.2 Durvet Description and Business Overview
6.6.3 Durvet Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Durvet Canine Vaccine Product Portfolio
6.6.5 Durvet Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Elanco Canine Vaccine Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 RuiPu Bio-Technology
6.8.1 RuiPu Bio-Technology Company Information
6.8.2 RuiPu Bio-Technology Description and Business Overview
6.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
6.8.5 RuiPu Bio-Technology Recent Developments/Updates
6.9 CAHIC
6.9.1 CAHIC Company Information
6.9.2 CAHIC Description and Business Overview
6.9.3 CAHIC Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CAHIC Canine Vaccine Product Portfolio
6.9.5 CAHIC Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Company Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Jilin Five-Star Animal Health
6.11.1 Jilin Five-Star Animal Health Company Information
6.11.2 Jilin Five-Star Animal Health Description and Business Overview
6.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates
6.12 NeoTech
6.12.1 NeoTech Company Information
6.12.2 NeoTech Description and Business Overview
6.12.3 NeoTech Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 NeoTech Canine Vaccine Product Portfolio
6.12.5 NeoTech Recent Developments/Updates
6.13 JINHE
6.13.1 JINHE Company Information
6.13.2 JINHE Description and Business Overview
6.13.3 JINHE Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JINHE Canine Vaccine Product Portfolio
6.13.5 JINHE Recent Developments/Updates
6.14 SINOVAC
6.14.1 SINOVAC Company Information
6.14.2 SINOVAC Description and Business Overview
6.14.3 SINOVAC Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 SINOVAC Canine Vaccine Product Portfolio
6.14.5 SINOVAC Recent Developments/Updates
6.15 Biogenesis Bago
6.15.1 Biogenesis Bago Company Information
6.15.2 Biogenesis Bago Description and Business Overview
6.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Biogenesis Bago Canine Vaccine Product Portfolio
6.15.5 Biogenesis Bago Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Canine Vaccine Industry Chain Analysis
7.2 Canine Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Canine Vaccine Production Mode & Process Analysis
7.4 Canine Vaccine Sales and Marketing
7.4.1 Canine Vaccine Sales Channels
7.4.2 Canine Vaccine Distributors
7.5 Canine Vaccine Customer Analysis
8 Canine Vaccine Market Dynamics
8.1 Canine Vaccine Industry Trends
8.2 Canine Vaccine Market Drivers
8.3 Canine Vaccine Market Challenges
8.4 Canine Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Canine Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Canine Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Canine Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Canine Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Canine Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Canine Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Canine Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Canine Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Canine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Canine Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Canine Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Canine Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Canine Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Canine Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Canine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Canine Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Canine Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Canine Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Canine Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Canine Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Canine Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Canine Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Canine Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Canine Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Canine Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Canine Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Canine Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Canine Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Canine Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Canine Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Canine Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Canine Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Canine Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Canine Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Canine Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Canine Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Canine Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Canine Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Canine Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Canine Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Canine Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Canine Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Canine Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Canine Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Canine Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Canine Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Canine Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Canine Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Canine Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Canine Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Canine Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Canine Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Canine Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Canine Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Canine Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Canine Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zoetis Canine Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Animal Health Canine Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Canine Vaccine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Boehringer Ingelheim Company Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Boehringer Ingelheim Canine Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Virbac Company Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Virbac Canine Vaccine Product
Table 94. Virbac Recent Developments/Updates
Table 95. Durvet Company Information
Table 96. Durvet Description and Business Overview
Table 97. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Durvet Canine Vaccine Product
Table 99. Durvet Recent Developments/Updates
Table 100. Elanco Company Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Elanco Canine Vaccine Product
Table 104. Elanco Recent Developments/Updates
Table 105. RuiPu Bio-Technology Company Information
Table 106. RuiPu Bio-Technology Description and Business Overview
Table 107. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RuiPu Bio-Technology Canine Vaccine Product
Table 109. RuiPu Bio-Technology Recent Developments/Updates
Table 110. CAHIC Company Information
Table 111. CAHIC Description and Business Overview
Table 112. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CAHIC Canine Vaccine Product
Table 114. CAHIC Recent Developments/Updates
Table 115. Wuhan Keqian Biology Company Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Wuhan Keqian Biology Canine Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Jilin Five-Star Animal Health Company Information
Table 121. Jilin Five-Star Animal Health Description and Business Overview
Table 122. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jilin Five-Star Animal Health Canine Vaccine Product
Table 124. Jilin Five-Star Animal Health Recent Developments/Updates
Table 125. NeoTech Company Information
Table 126. NeoTech Description and Business Overview
Table 127. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. NeoTech Canine Vaccine Product
Table 129. NeoTech Recent Developments/Updates
Table 130. JINHE Company Information
Table 131. JINHE Description and Business Overview
Table 132. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. JINHE Canine Vaccine Product
Table 134. JINHE Recent Developments/Updates
Table 135. SINOVAC Company Information
Table 136. SINOVAC Description and Business Overview
Table 137. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. SINOVAC Canine Vaccine Product
Table 139. SINOVAC Recent Developments/Updates
Table 140. Biogenesis Bago Company Information
Table 141. Biogenesis Bago Description and Business Overview
Table 142. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Biogenesis Bago Canine Vaccine Product
Table 144. Biogenesis Bago Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Canine Vaccine Distributors List
Table 148. Canine Vaccine Customers List
Table 149. Canine Vaccine Market Trends
Table 150. Canine Vaccine Market Drivers
Table 151. Canine Vaccine Market Challenges
Table 152. Canine Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Canine Vaccine
Figure 2. Global Canine Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Canine Vaccine Market Share by Type: 2025 & 2032
Figure 4. Core Vaccines Product Picture
Figure 5. Non-Core Vaccines Product Picture
Figure 6. Global Canine Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Canine Vaccine Market Share by Application: 2025 & 2032
Figure 8. Puppies
Figure 9. Adult Dogs
Figure 10. Global Canine Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Canine Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global Canine Vaccine Sales (K Units), 2021–2032
Figure 13. Global Canine Vaccine Average Price (US$/Unit), 2021–2032
Figure 14. Canine Vaccine Report Years Considered
Figure 15. Canine Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global Canine Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Canine Vaccine Players: Market Share by Revenue in Canine Vaccine in 2025
Figure 18. Canine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Canine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Canine Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Canine Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Canine Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of Canine Vaccine by Type (2021–2032)
Figure 53. Global Canine Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Canine Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of Canine Vaccine by Application (2021–2032)
Figure 56. Global Canine Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 57. Canine Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Canine Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Canine Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Canine Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Canine Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Canine Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Canine Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Canine Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Canine Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Canine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Canine Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Canine Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Canine Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Canine Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Canine Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Canine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Canine Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Canine Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Canine Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Canine Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Canine Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Canine Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Canine Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Canine Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Canine Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Canine Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Canine Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Canine Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Canine Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Canine Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Canine Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Canine Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Canine Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Canine Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Canine Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Canine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Canine Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Canine Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Canine Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Canine Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Canine Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Canine Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Canine Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Canine Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Canine Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Canine Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Canine Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Canine Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Canine Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Canine Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Canine Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Canine Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Canine Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Canine Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Canine Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Canine Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Canine Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Canine Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Canine Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Canine Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zoetis Canine Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Merck Animal Health Canine Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer Canine Vaccine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Boehringer Ingelheim Company Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Boehringer Ingelheim Canine Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Virbac Company Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Virbac Canine Vaccine Product
Table 94. Virbac Recent Developments/Updates
Table 95. Durvet Company Information
Table 96. Durvet Description and Business Overview
Table 97. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Durvet Canine Vaccine Product
Table 99. Durvet Recent Developments/Updates
Table 100. Elanco Company Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Elanco Canine Vaccine Product
Table 104. Elanco Recent Developments/Updates
Table 105. RuiPu Bio-Technology Company Information
Table 106. RuiPu Bio-Technology Description and Business Overview
Table 107. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RuiPu Bio-Technology Canine Vaccine Product
Table 109. RuiPu Bio-Technology Recent Developments/Updates
Table 110. CAHIC Company Information
Table 111. CAHIC Description and Business Overview
Table 112. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CAHIC Canine Vaccine Product
Table 114. CAHIC Recent Developments/Updates
Table 115. Wuhan Keqian Biology Company Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Wuhan Keqian Biology Canine Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Jilin Five-Star Animal Health Company Information
Table 121. Jilin Five-Star Animal Health Description and Business Overview
Table 122. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Jilin Five-Star Animal Health Canine Vaccine Product
Table 124. Jilin Five-Star Animal Health Recent Developments/Updates
Table 125. NeoTech Company Information
Table 126. NeoTech Description and Business Overview
Table 127. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. NeoTech Canine Vaccine Product
Table 129. NeoTech Recent Developments/Updates
Table 130. JINHE Company Information
Table 131. JINHE Description and Business Overview
Table 132. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. JINHE Canine Vaccine Product
Table 134. JINHE Recent Developments/Updates
Table 135. SINOVAC Company Information
Table 136. SINOVAC Description and Business Overview
Table 137. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. SINOVAC Canine Vaccine Product
Table 139. SINOVAC Recent Developments/Updates
Table 140. Biogenesis Bago Company Information
Table 141. Biogenesis Bago Description and Business Overview
Table 142. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Biogenesis Bago Canine Vaccine Product
Table 144. Biogenesis Bago Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Canine Vaccine Distributors List
Table 148. Canine Vaccine Customers List
Table 149. Canine Vaccine Market Trends
Table 150. Canine Vaccine Market Drivers
Table 151. Canine Vaccine Market Challenges
Table 152. Canine Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Canine Vaccine
Figure 2. Global Canine Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Canine Vaccine Market Share by Type: 2025 & 2032
Figure 4. Core Vaccines Product Picture
Figure 5. Non-Core Vaccines Product Picture
Figure 6. Global Canine Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Canine Vaccine Market Share by Application: 2025 & 2032
Figure 8. Puppies
Figure 9. Adult Dogs
Figure 10. Global Canine Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Canine Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global Canine Vaccine Sales (K Units), 2021–2032
Figure 13. Global Canine Vaccine Average Price (US$/Unit), 2021–2032
Figure 14. Canine Vaccine Report Years Considered
Figure 15. Canine Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global Canine Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Canine Vaccine Players: Market Share by Revenue in Canine Vaccine in 2025
Figure 18. Canine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Canine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Canine Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Canine Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Canine Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Canine Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Canine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Canine Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of Canine Vaccine by Type (2021–2032)
Figure 53. Global Canine Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Canine Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of Canine Vaccine by Application (2021–2032)
Figure 56. Global Canine Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 57. Canine Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232